Your Trial is at Risk And
You Can’t Afford Non-Adherence!
The High Cost of Poor Adherence
You already know what happens when adherence fails.
​
-
Missed doses = compromised endpoints.
-
Protocol deviations = longer trials, higher costs.
-
FDA scrutiny = delays, lost funding, and frustrated sponsors.
The question isn’t whether adherence tracking needs to improve.
​
The question is: Who will lead the shift toward validated adherence data?
The Industry is Moving—
And Trials MUST Adapt
The FDA is mandating real-world adherence tracking: Trials that rely on self-reporting are at risk of increased scrutiny, loss of funding, and approval delays.
​
Missed doses = corrupted data = trial failure: Deviations increase costs, cause delays, and put endpoints at risk.
​
Decentralized trials are becoming the norm: CROs need a passive, automated adherence solution to stay competitive.
​
The trials moving first will establish the industry standard. The ones that wait? They’ll get left behind.
RxKeeper: The First Passive Adherence Solution Built for Clinical Trials
100% RTM-Billable Under Medicare – A new revenue stream without disrupting your workflow.
No Apps, No WiFi, No Behavior Change – Patients simply store their meds inside.
Battery-Operated, Cellular-Connected, Real-Time Adherence Tracking – Adherence data feeds directly into your RPM platform.
​
Seamless capture of Electronic Patient-Reported Outcomes (ePRO) on the RxKeeper Container
Seamless RPM Integration – No additional staff training is required.
Reduces Hospitalizations, Improves Outcomes – Providers retain patients, reduce costs, and improve quality scores.
In Stock & Ready to Deploy – No R&D, no delays—just revenue.
While potential competitors are figuring out compliance, RxKeeper is already selling.
How RxKeeper® Works: Verification Made Simple
-
Participants store their medication in RxKeeper.
-
RxKeeper detects when medication is accessed.
-
Data is transmitted instantly via wifi or cellular network.
-
Researchers receive real-time adherence reports.
-
No more missing doses. No more noncompliant patient recalls.
No apps. No WiFi. No patient burden. Just compliance certainty.
The Trials That Move First Will Lead the Industry
Sponsors are demanding better adherence tracking.
FDA scrutiny is increasing—manual self-reporting won’t be enough.
CROs that deliver validated adherence data will win more sponsor contracts.
The shift is already happening.
Which CROs will own this space—and which will struggle to keep up?
"Missed doses lead to bad data. Bad data leads to failed trials. RxKeeper eliminates that risk."
Six months from now, sponsors will expect real-time adherence tracking. Will your trials be ready?
Lock in compliance before regulators demand it​,
→ Let's have a conversation